Watch CBS News

23andMe to lay off 40% of its workforce

The genetic testing company 23andMe is cutting 40% of its workforce and ending its therapeutics program as its stock price continues to plummet. CBS News correspondent Carter Evans has more on what this means for its customers.
Nov 13, 2024 (01:50)
Videos
View CBS News In
CBS News App Open
Chrome Safari Continue